基于生物信息学分析FAM189A2在食管癌中的表达及临床意义
王元国, 张鹏天津医科大学总医院心胸外科, 天津 300052
收稿日期:
2022-11-08出版日期:
2023-03-30发布日期:
2023-03-21通讯作者:
张鹏E-mail:zhangfapeng@aliyun.com作者简介:
王元国(1984-),男,主管技师,硕士.基金资助:
京津冀基础研究合作专项(20JCZXJC00190);天津市自然科学基金(19JCZDJC35500)关键词: 食管癌, 生物信息学, 预后
Abstract: Objective To investigate the expression and clinical significance of FAM189A2 in esophageal carcinoma using information from a variety of databases. Methods Using UALCAN,a pan-cancer analysis of FAM189A2 expression was performed,and the relationship between FAM189A2 expression level,esophageal cancer stage,TP53 mutation and methylation level was analyzed. The expression of FAM189A2 in esophageal cancer and normal esophageal tissue was determined using RT-PCR. The relationship between prognosis and FAM189A2 expression was analyzed using the GEPIA database,co-expressed genes were screened by the cBioportal and STRING databases and a regulatory network was constructed. The DAVID database was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Results The expression level of FAM189A2 mRNA in esophageal cancer was significantly lower than that in normal tissues (P<0.05) and was correlated with clinical stage and TP53 mutation status. The differences were statistically significant (P<0.05). Patients with low FAM189A2 expression in esophageal cancer had poor prognosis (P<0.05). The low expression of FAM189A2 may be related to gene methylation. GO and KEGG enrichment analysis showed that the gene that co-expressed with FAM189A2 was mainly involved in intracellular signaling and the PI3K-Akt signaling pathway. Conclusion The expression of FAM189A2 in esophageal cancer is lower than that in normal tissues,and the prognosis of patients with low expression is poor. The expression of FAM189A2 is closely related to tumor stage,pathological type and TP53 mutation status.
Key words: esophageal cancer, bioinformatics, prognosis
PDF全文下载地址:
https://journal.cmu.edu.cn/CN/article/downloadArticleFile.do?attachType=PDF&id=3177